 | Should AbbVie Inc. Have a Place in Your Dividend Portfolio?
marketbeat.com - August 26 at 1:05 AM |
| Are Medtronic And Intuitive Surgical Poised For Big Growth? (ABBV)
marketbeat.com - August 9 at 10:27 AM |
| Two Appealing Biotech Stocks for Two Distinct investors (ABBV)
marketbeat.com - August 8 at 11:11 AM |
| 3 Pharma Stocks' Post-Earnings Price Moves
marketbeat.com - August 4 at 6:05 AM |
 | How Far Will AbbVie's Humira Revenue Fall in 2023?
finance.yahoo.com - October 1 at 7:56 PM |
 | Here's Why This Dividend King Is a Buy - The Motley Fool
fool.com - October 1 at 9:55 AM |
| Here's Why This Dividend King Is a Buy
finance.yahoo.com - October 1 at 9:55 AM |
 | 7 Analysts Have This to Say About AbbVie - AbbVie (NYSE:ABBV) - Benzinga
benzinga.com - September 30 at 6:52 PM |
 | ABBV stock pares losses as SVB Leerink retracts guidance claims (NYSE:ABBV) - Seeking Alpha
seekingalpha.com - September 30 at 6:52 PM |
 | We're upgrading our rating on AbbVie amid a false report on the biopharma's guidance - CNBC
cnbc.com - September 30 at 6:52 PM |
|
 | 3 Safe Stocks You'll Want to Have Exposure to in 2022
stocknews.com - September 30 at 4:17 PM |
| Analyzing AbbVie's Short Interest - AbbVie (NYSE:ABBV) - Benzinga
benzinga.com - September 30 at 1:51 PM |
| AbbVie pares losses as SVB Leerink retracts guidance claims
seekingalpha.com - September 30 at 1:26 PM |
| Where Will AbbVie Be in 3 Years? - The Motley Fool
fool.com - September 30 at 8:15 AM |
| Where Will AbbVie Be in 3 Years?
finance.yahoo.com - September 30 at 8:15 AM |
| AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn's Disease and Ulcerative Colitis at the UEG Week 2022
finance.yahoo.com - September 29 at 7:14 AM |
| AbbVie Inc. (NYSE:ABBV) is a favorite amongst institutional investors who own 70%
finance.yahoo.com - September 28 at 9:58 AM |
| 2 High-Yielding Dividend Stocks That Could Raise Their Payouts in October - The Motley Fool
fool.com - September 28 at 4:57 AM |
| XEN® 63 Gel Implant available now for patients with primary open angle glaucoma where previous medical treatments have failed
finance.yahoo.com - September 27 at 8:40 AM |
| Check Out What Whales Are Doing With ABBV - AbbVie (NYSE:ABBV) - Benzinga
benzinga.com - September 26 at 5:39 PM |
| 3 Stocks to Get Bullish on Right Now
stocknews.com - September 26 at 3:57 PM |
| AbbVie Stock Is One To Watch As It Sees RS Rating Jump To 91
finance.yahoo.com - September 26 at 12:39 PM |
| AbbVie Inc.'s (NYSE:ABBV) Business Is Trailing The Market But Its Shares Aren't - Yahoo Finance
finance.yahoo.com - September 24 at 6:18 PM |
| Is AbbVie a Buy? - The Motley Fool
fool.com - September 24 at 8:17 AM |
| AbbVie Inc.'s (NYSE:ABBV) Business Is Trailing The Market But Its Shares Aren't
finance.yahoo.com - September 24 at 8:17 AM |
| Got $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond - The Motley Fool
fool.com - September 23 at 12:11 PM |
 | What Could This Drug News Mean for AbbVie? - Nasdaq
nasdaq.com - September 23 at 12:11 PM |
| Got $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond
finance.yahoo.com - September 23 at 12:11 PM |
| What Could This Drug News Mean for AbbVie? - The Motley Fool
fool.com - September 23 at 7:10 AM |
| Use These 3 Simple Tricks to Maximize Your Returns From AbbVie Stock - The Motley Fool
fool.com - September 23 at 7:10 AM |
| What Could This Drug News Mean for AbbVie?
finance.yahoo.com - September 23 at 7:10 AM |
| Use These 3 Simple Tricks to Maximize Your Returns From AbbVie Stock
finance.yahoo.com - September 23 at 7:10 AM |
|
| 4 Stocks to Buy With Market-Beating Potential
stocknews.com - September 22 at 2:16 PM |
| The Forces of Beauty® Report from The DREAM Initiative® Reveals Demand for New Standards of Beauty and Imagery
finance.yahoo.com - September 22 at 12:10 PM |
 | Global Cancer Stem Cell Market to 2030 - Featuring Thermo Fisher Scientific, AbbVie and Lonza Among Others - ResearchAndMarkets.com - Business Wire
businesswire.com - September 21 at 2:13 PM |
| The Zacks Analyst Blog Highlights Apple, Amazon, AbbVie, Philip Morris International and BlackRock - Nasdaq
nasdaq.com - September 21 at 9:12 AM |
| 3 Stocks Bullish Traders Tend to Fall in Love With
stocknews.com - September 20 at 1:30 PM |
| AbbVie Stock: Small Hurdle (NYSE:ABBV) - Seeking Alpha
seekingalpha.com - September 20 at 4:36 AM |
| The Zacks Analyst Blog Highlights AbbVie, Novartis, Merck and AstraZeneca - Nasdaq
nasdaq.com - September 19 at 11:35 PM |
| AbbVie: Small Hurdle
seekingalpha.com - September 19 at 11:11 PM |
| Outlook on the Analgesics Global Market to 2028 - Featuring AbbVie, Abbott Laboratories, Bayer and Endo International Among Others - ResearchAndMarkets.com - Business Wire
businesswire.com - September 19 at 6:35 PM |
| Top Analyst Reports for Apple, Amazon.com & AbbVie
finance.yahoo.com - September 19 at 6:35 PM |
| AbbVie Receives CHMP Positive Opinion For Skyrizi For Moderate To Severe Crohn's Disease
nasdaq.com - September 19 at 1:19 PM |
 | Calif. Pharmaceutical Companies AbbVie And Bristol Myers Lay Off 360—Here Are The Major U.S. Layoffs This Summer
msn.com - September 19 at 1:19 PM |
| European Authority Backs AbbVie's Crohn's Disease Candidate
msn.com - September 19 at 1:19 PM |
| AbbVie Inc.: Diving Into the Drug Pricing Hit From the Inflation Reduction Act, We’ve Reduced Our FVEs by 2%
finance.yahoo.com - September 19 at 1:19 PM |
| AbbVie: Valuation Attractive Due To Humira Headwinds
seekingalpha.com - September 19 at 1:19 PM |
| AbbVie Vs. Pfizer: Which Is A Better High-Yield Pick (NYSE:ABBV) (NYSE:PFE) - Seeking Alpha
seekingalpha.com - September 19 at 8:19 AM |
 | Bristol Myers, AbbVie plan to cut up to 360 California jobs - Reuters
reuters.com - September 18 at 1:17 AM |
| 3 Safe Investments for Seniors to Consider Right Now
stocknews.com - September 16 at 6:51 PM |
| Outlook For AbbVie Continues To Look Favorable (NYSE:ABBV) - Seeking Alpha
seekingalpha.com - September 16 at 8:54 AM |
| Outlook For AbbVie Continues To Look Favorable
seekingalpha.com - September 15 at 6:49 PM |
| This 1 Stock Pays You Just for Owning It
stocknews.com - September 15 at 10:42 AM |
| AbbVie to Present Data from Growing Neuroscience and Movement Disorders Portfolio at 2022 MDS International Congress
finance.yahoo.com - September 15 at 5:15 AM |
